Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 1/16: Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12257229 | Peptide pharmaceuticals for treatment of NASH and other disorders | Dec 20, 22 | Mar 25, 25 | Spitfire Pharma LLC |
| 12257234 | Methods of treating fibrotic liver diseases or conditions with indeglitazar | Jul 12, 24 | Mar 25, 25 | PLEIOGENIX INC. |
| 12258317 | Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof | May 20, 20 | Mar 25, 25 | SUNSHINE LAKE PHARMA CO., LTD |
| 12251364 | Treating non-alcoholic steatohepatitis with cck inhibitors | Nov 05, 19 | Mar 18, 25 | Georgetown University |
| 12251409 | Use of cyanobacterial biomass in treating hepatitis B virus infection | May 15, 20 | Mar 18, 25 | FAR EAST BIO-TEC CO., LTD. |
| 12252703 | Closed-ended linear duplex DNA for non-viral gene transfer | Jun 01, 21 | Mar 18, 25 | UNIVERSITY OF MASSACHUSETTS; Voyager Therapeutics, Inc.; |
| 12239622 | Compositions comprising amino acids for use in the prevention and treatment of liver diseases | Apr 02, 19 | Mar 04, 25 | Professional Dietetics S.P.A. |
| 12239641 | Methods of treating or preventing fibrosis in non-alcoholic fatty liver disease | Sep 25, 20 | Mar 04, 25 | Not available |
| 12239683 | Synergistic hepatoprotective composition | Apr 18, 19 | Mar 04, 25 | FFF BIOWORKS LLP |
| 12240841 | FXR small molecule agonist and preparation method therefor and use thereof | Apr 20, 20 | Mar 04, 25 | Shanghai Institute of Materia Medica Chinese Academy of Sciences; Van Andel Research Institute; |
| 12240876 | Liver-specific Wnt signal enhancing molecules and uses thereof | May 02, 23 | Mar 04, 25 | Surrozen Operating, Inc. |
| 12239712 | Combination therapy for the treatment of liver disease | Sep 03, 19 | Mar 04, 25 | GALMED RESEARCH AND DEVELOPMENT LTD. |
| 12233107 | GHRH or analogues thereof for use in treatment of hepatic disease | Jul 12, 23 | Feb 25, 25 | The General Hospital Corporation |
| 12226411 | Soluble guanylate cyclase activators for treating portal hypertension | Mar 20, 23 | Feb 18, 25 | Boehringer Ingelheim International GmbH |
| 12226417 | Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists | Jan 26, 23 | Feb 18, 25 | Corcept Therapeutics, Inc. |
| 12226423 | Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide | Jun 28, 22 | Feb 18, 25 | Virginia Commonwealth University; Durect Corporation; The United States Government as Represented by the Department of Veterans Affairs; |
| 12226487 | Therapeutic derivatives of interleukin-22 | Apr 05, 24 | Feb 18, 25 | Cytoki Pharma ApS |
| 12227499 | Fused imidazole derivative, preparation method therefor, and medical use thereof | Sep 01, 21 | Feb 18, 25 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| 12220405 | Compositions for the treatment of hepatic steatosis | Jun 08, 21 | Feb 11, 25 | Not available |
| 12221422 | Compounds and their use for the treatment of alpha1-antitrypsin deficiency | Mar 21, 22 | Feb 11, 25 | CENTESSA PHARMACEUTICALS (UK) LIMITED |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2025/0114,355 | TREATING LIVER DISEASE | May 09, 22 | Apr 10, 25 | Not available |
| 2025/0115,639 | HANGTAIMYCIN DERIVATIVES AND THEIR PREPARATION METHODS AND APPLICATION | Nov 22, 24 | Apr 10, 25 | WUHAN UNIVERSITY |
| 2025/0108,075 | METHODS OF ADMINISTERING COMPOSITIONS OF BACILLUS SUBTILIS PB6, BUTYRIC ACID WITH ZINC, AND OPTIONALLY RED CLOVER, TO REDUCE LIVER ABSCESSES IN CATTLE | Sep 30, 24 | Apr 03, 25 | Not available |
| 2025/0108,076 | METHODS FOR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD) USING ADVANCED MICROBIOME THERAPEUTICS | Apr 24, 23 | Apr 03, 25 | Not available |
| 2025/0109,154 | LYSOPHOSPHATIDYLSERINE ANALOGUE, AND LYSOPHOSPHATIDYLSERINE ANALOGUE-CONTAINING PHAMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING FIBROSIS | Jan 27, 23 | Apr 03, 25 | Japan as represented by President of the University of Tokyo |
| 2025/0099,383 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | Jan 20, 23 | Mar 27, 25 | Not available |
| 2025/0099,468 | TREATING LIVER DISORDERS WITH AN SSAO INHIBITOR | Dec 11, 24 | Mar 27, 25 | Not available |
| 2025/0100,983 | BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS | Sep 25, 24 | Mar 27, 25 | Not available |
| 2025/0101,120 | ANTIBODIES SPECIFICALLY RECOGNIZING FASL AND USES THEREOF | Jan 16, 23 | Mar 27, 25 | Not available |
| 2025/0090,515 | 1-Deoxynojirimycin To Mitigate Hepatic Ischemia- Reperfusion | Sep 18, 23 | Mar 20, 25 | Not available |
| 2025/0090,606 | COMPOSITIONS FOR TREATMENT OF A FATTY LIVER OR FIBROTIC LIVER DISEASE | Jan 13, 23 | Mar 20, 25 | Not available |
| 2025/0092,403 | COMPOSITIONS AND METHODS FOR INHIBITING KETOHEXOKINASE (KHK) | Apr 22, 24 | Mar 20, 25 | Not available |
| 2025/0092,041 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | Nov 22, 24 | Mar 20, 25 | Chugai Seiyaku Kabushiki Kaisha |
| 2025/0092,126 | TREATMENT AND PREVENTION OF ALCOHOLIC LIVER DISEASE | Jul 26, 22 | Mar 20, 25 | Boehringer Ingelheim International GmbH |
| 2025/0082,616 | Solid Dispersion Forms of Rifaximin | Nov 25, 24 | Mar 13, 25 | Not available |
| 2025/0082,654 | AZD3355 (LESOGABERAN) FOR TREATMENT AND PREVENTION OF NONALCOHOLIC STEATOHEPATITIS (NASH), LIVER FIBROSIS, AND OTHER LIVER CONDITIONS | Sep 16, 24 | Mar 13, 25 | Icahn School of Medicine at Mount Sinai |
| 2025/0082,690 | SHEET-SHAPED CELL CULTURE FOR TREATING LIVER DYSFUNCTION | Jul 09, 24 | Mar 13, 25 | Not available |
| 2025/0082,706 | FERMENTED GINSENG RADIX ET RHIZOMA EXTRACT, PRODUCT FOR ALLEVIATING NON-ALCOHOLIC FATTY LIVER DISEASE, METHOD FOR PROMOTING INCREASE OF CONTENT OF AGLYCONE FLAVONOIDS AND/OR SHORT-CHAIN FATTY ACIDS IN GINSENG RADIX ET RHIZOMA EXTRACT, AND METHOD FOR PROMOTING EFFICACY OF GINSENG RADIX ET RHIZOMA EXTRACT IN ALLEVIATING NON-ALCOHOLIC FATTY LIVER DISEASE | Jun 18, 24 | Mar 13, 25 | INFINITUS (CHINA) COMPANY LTD. |
| 2025/0084,072 | GLP-1R MODULATING COMPOUNDS | Aug 20, 24 | Mar 13, 25 | Not available |
| 2025/0073,247 | MURICHOLIC ACIDS AND DERIVATIVES FOR CHOLESTASIS TREATMENT | Sep 03, 24 | Mar 06, 25 | Not available |
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
